Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
In this study, we investigated lipidome profile in human renal cell carcinoma (RCC) tissues with an original method using mass spectrometry. By correlating with clinical data, we discovered novel biomarker candidates that contribute to the oncological outcome in patients with RCC. In the future, we also aim to become a novel treatment strategy for RCC by analysis of targeting related enzymes.
|